American Injectables Announces Key Leadership Appointments to Drive Future Growth
American Injectables, a leading contract development and manufacturing organization (CDMO) specializing in sterile injectables, recently announced str...
Read More
American Injectables Earns FDA Approval
BROOKSVILLE, FL (January 9, 2025) — American Injectables, a contract development and manufacturing o...
A Business-Minded Guide to Injectable Solutions and Market Trends
You don’t need a PhD in biochemistry to work in the pharmaceutical industry. However, understanding ...
Pharmaceutical Data Integrity: Protecting Your Branded Formulation
Imagine spending years and hundreds of thousands of dollars on a formulation, only to have it compro...
Special Considerations for Developing Parenteral Formulations
Compared to oral and transdermal medicine, parenteral formulations are potent and fast-acting. With ...
Strengthening the Pharmaceutical Supply Chain: It Starts With Formulation
The effects of supply chain issues are often most noticeable at the consumer level, manifesting as p...
Developing a Regulatory Strategy: Key Studies in the Formulation Stage
The FDA approval process is time-intensive and difficult for good reason. If you emerge on the other...
Formulation Development Process for Injectables: Your Steps to Success [Graphic]
Formulation development can take as long as three U.S. presidential terms. With that kind of time, i...
American Injectables Rolls Out Bold Rebrand
Brooksville, FL (July 11, 2024) — American Injectables, a pharmaceutical CDMO, recently debuted thei...
American Injectables Announces Validation of Its Tampa Operations
American Injectables is now well positioned to help fill the gap in US-based manufacturing of steril...